MBIO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Mustang Bio Inc (MBIO).


$8.46M Market Cap.

As of 03/28/2025 5:00 PM ET (MRY) • Disclaimer

MBIO Market Cap. (MRY)


MBIO Shares Outstanding (MRY)


MBIO Assets (MRY)


Total Assets

$9.31M

Total Liabilities

$13.18M

Total Investments

$0

MBIO Income (MRY)


Revenue

$0

Net Income

-$15.75M

Operating Expense

$16.25M

MBIO Cash Flow (MRY)


CF Operations

-$11.41M

CF Investing

$0

CF Financing

$11.27M

MBIO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

MBIO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$9,308,000 (-47.54%)

$17,742,000 (-80.80%)

$92,422,000 (-26.16%)

$125,170,000 (13.89%)

Assets Current

$8,606,000 (-24.15%)

$11,346,000 (-85.61%)

$78,852,000 (-29.41%)

$111,706,000 (12.23%)

Assets Non-Current

$702,000 (-89.02%)

$6,396,000 (-52.87%)

$13,570,000 (0.79%)

$13,464,000 (29.89%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$3,873,000 (-3248.78%)

$123,000 (-99.73%)

$46,273,000 (-58.83%)

$112,400,000 (14.19%)

Property Plant & Equipment Net

$1,617,000 (-66.40%)

$4,813,000 (-60.90%)

$12,309,000 (1.71%)

$12,102,000 (32.76%)

Cash & Equivalents

$6,839,000 (-2.08%)

$6,984,000 (-90.89%)

$76,656,000 (-30.70%)

$110,618,000 (11.96%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$150,000 (-44.44%)

$270,000 (0.00%)

$270,000 (0.00%)

$270,000 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$402,000 (-89.64%)

$3,879,000 (10675.00%)

$36,000 (-28.00%)

$50,000 (233.33%)

Trade & Non-Trade Payables

$12,153,000 (-18.17%)

$14,851,000 (2.44%)

$14,497,000 (38.50%)

$10,467,000 (13.32%)

Accumulated Retained Earnings (Deficit)

-$396,723,000 (-4.13%)

-$380,971,000 (-15.67%)

-$329,369,000 (-30.78%)

-$251,844,000 (-35.78%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$878,000 (-64.85%)

$2,498,000 (-92.04%)

$31,382,000 (1443.63%)

$2,033,000 (-8.75%)

Debt Current

$456,000 (-12.31%)

$520,000 (-15.03%)

$612,000 (75.86%)

$348,000 (25.18%)

Debt Non-Current

$422,000 (-78.67%)

$1,978,000 (-93.57%)

$30,770,000 (1726.11%)

$1,685,000 (-13.59%)

Total Liabilities

$13,181,000 (-25.19%)

$17,619,000 (-61.82%)

$46,149,000 (261.39%)

$12,770,000 (11.38%)

Liabilities Current

$12,609,000 (-17.97%)

$15,371,000 (1.73%)

$15,109,000 (39.70%)

$10,815,000 (13.66%)

Liabilities Non-Current

$572,000 (-74.56%)

$2,248,000 (-92.76%)

$31,040,000 (1487.72%)

$1,955,000 (0.26%)

MBIO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$4,135,000 (-57.31%)

$9,686,000 (-20.67%)

$12,210,000 (10.83%)

$11,017,000 (15.91%)

Research & Development Expense

$8,418,000 (-79.49%)

$41,040,000 (-35.82%)

$63,949,000 (14.80%)

$55,706,000 (17.77%)

Operating Expenses

$16,245,000 (-67.02%)

$49,260,000 (-35.32%)

$76,159,000 (14.14%)

$66,723,000 (17.46%)

Interest Expense

$5,000 (-99.88%)

$4,109,000 (22.33%)

$3,359,000 (22293.33%)

$15,000 (-99.62%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$15,752,000 (69.47%)

-$51,602,000 (33.44%)

-$77,525,000 (-16.81%)

-$66,370,000 (-10.59%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$15,752,000 (69.47%)

-$51,602,000 (33.44%)

-$77,525,000 (-16.81%)

-$66,370,000 (-10.59%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$15,752,000 (69.47%)

-$51,602,000 (33.44%)

-$77,525,000 (-16.81%)

-$66,370,000 (-10.59%)

Weighted Average Shares

$609,696 (-92.91%)

$8,604,104 (24.78%)

$6,895,541 (17.69%)

$5,859,045 (67.12%)

Weighted Average Shares Diluted

$609,696 (-92.91%)

$8,604,104 (24.78%)

$6,895,541 (17.69%)

$5,859,045 (67.12%)

Earning Before Interest & Taxes (EBIT)

-$15,747,000 (66.84%)

-$47,493,000 (35.96%)

-$74,166,000 (-11.77%)

-$66,355,000 (-18.28%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$16,245,000 (67.02%)

-$49,260,000 (35.32%)

-$76,159,000 (-14.14%)

-$66,723,000 (-17.46%)

MBIO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$5,886,000 (299.39%)

-$2,952,000 (44.99%)

-$5,366,000 (-21.62%)

Net Cash Flow from Financing

$11,265,000 (143.19%)

-$26,081,000 (-176.58%)

$34,056,000 (-51.93%)

$70,847,000 (-9.31%)

Net Cash Flow from Operations

-$11,410,000 (76.94%)

-$49,477,000 (23.96%)

-$65,066,000 (-21.24%)

-$53,667,000 (-43.81%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$145,000 (99.79%)

-$69,672,000 (-105.15%)

-$33,962,000 (-387.47%)

$11,814,000 (-67.54%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$5,936,000 (329.45%)

-$2,587,000 (35.10%)

-$3,986,000 (-107.06%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$30,375,000 (-201.25%)

$30,000,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$11,367,000 (139.86%)

$4,739,000 (-30.60%)

$6,829,000 (-90.55%)

$72,228,000 (-25.83%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

-$450,000 (-179.23%)

$568,000 (-75.12%)

$2,283,000 (-30.99%)

$3,308,000 (10.75%)

Depreciation Amortization & Accretion

$823,000 (-63.01%)

$2,225,000 (-26.59%)

$3,031,000 (31.44%)

$2,306,000 (29.19%)

MBIO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

244.20% (156.38%)

-433.10% (-304.77%)

-107.00% (-102.65%)

-52.80% (35.84%)

Return on Average Assets (ROAA)

-159.10% (-8.67%)

-146.40% (-117.21%)

-67.40% (-38.40%)

-48.70% (26.66%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

190.00% (132.86%)

-578.20% (-152.82%)

-228.70% (78.16%)

-1047.30% (-77.99%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.23 (-1.78%)

-0.23 (57.31%)

-0.53 (75.87%)

-2.18 (34.22%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

-2.18 (-102.16%)

101.16 (10944.10%)

0.92 (-33.62%)

1.38 (-45.00%)

Debt to Equity Ratio (D/E)

-3.4 (-102.38%)

143.24 (14267.50%)

1 (774.56%)

0.11 (-1.72%)

Earnings Per Share (EPS)

-38.57 (-542.83%)

-6 (46.67%)

-11.25 (1.32%)

-11.4 (33.33%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-18.71 (-269.84%)

-5.06 (48.43%)

-9.81 (0.29%)

-9.84 (12.10%)

Book Value Per Share (BVPS)

-6.35 (-45471.43%)

0.01 (-99.79%)

6.71 (-65.02%)

19.18 (-31.67%)

Tangible Assets Book Value Per Share (TABVPS)

15.27 (640.40%)

2.06 (-84.62%)

13.4 (-37.26%)

21.36 (-31.85%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

-1 (66.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.37 (-256.73%)

-0.1 (-139.54%)

0.26 (147.73%)

-0.55 (82.70%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

0.68 (-7.45%)

0.74 (-85.86%)

5.22 (-49.47%)

10.33 (-1.26%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$11,410,000 (73.79%)

-$43,541,000 (35.64%)

-$67,653,000 (-17.35%)

-$57,653,000 (-46.91%)

Enterprise Value (EV)

$5,540,104 (17.72%)

$4,706,206 (125.15%)

-$18,710,569 (-153.00%)

$35,303,170 (-79.59%)

Earnings Before Tax (EBT)

-$15,752,000 (69.47%)

-$51,602,000 (33.44%)

-$77,525,000 (-16.81%)

-$66,370,000 (-10.59%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$14,924,000 (67.03%)

-$45,268,000 (36.36%)

-$71,135,000 (-11.06%)

-$64,049,000 (-17.93%)

Invested Capital

-$9,262,000 (-337.92%)

-$2,115,000 (-106.60%)

$32,039,000 (455.27%)

$5,770,000 (51.48%)

Working Capital

-$4,003,000 (0.55%)

-$4,025,000 (-106.31%)

$63,743,000 (-36.82%)

$100,891,000 (12.08%)

Tangible Asset Value

$9,308,000 (-47.54%)

$17,742,000 (-80.80%)

$92,422,000 (-26.16%)

$125,170,000 (13.89%)

Market Capitalization

$8,457,104 (-32.03%)

$12,443,206 (-70.64%)

$42,374,431 (-72.68%)

$155,090,170 (-37.19%)

Average Equity

-$6,450,500 (-154.14%)

$11,915,000 (-83.56%)

$72,484,250 (-42.36%)

$125,750,000 (72.45%)

Average Assets

$9,903,000 (-71.91%)

$35,250,500 (-69.36%)

$115,031,000 (-15.56%)

$136,226,250 (50.79%)

Invested Capital Average

-$8,286,750 (-200.88%)

$8,214,500 (-74.67%)

$32,424,250 (411.75%)

$6,336,000 (-33.54%)

Shares

955,605 (-89.63%)

9,217,190 (28.85%)

7,153,650 (14.85%)

6,228,552 (43.21%)